Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Here’s a quick briefing of the new codes that come into effect on April 1 that your billing staff should know about.
The deal closed Feb.22, but the FTC has expressed concerns about the acquisition and Amazon’s business practices in general.
With COVID-19 testing demand all but dried up, labs will have to make—or at least contemplate making—significant changes to their business.
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
A code of conduct for sales and marketing staff is essential to allow staff to do their jobs while avoiding liability risk.
How to explain the current state of EKRA to your lab executives.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.